Discontinuing mood stabilizers often leads to relapse during pregnancy
The Carlat Psychiatry Report, Volume 6, Number 1, January 2008
https://www.thecarlatreport.com/newsletter-issue/tcprv6n1/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | Women's Issues in Psychiatry
John O’Reardon, MD
Although we tend to feel comfortable counseling patients to continue antidepressants during pregnancy, because most of them do not appear to cause congenital abnormalities, mood stabilizers are trickier.
You can't view details of this content, please login or buy subscription here
John O’Reardon, MD
Associate Professor of Psychiatry University of Pennsylvania Health System
Dr. O’Reardon has disclosed that he has received research grants from Neuronetics, Cyberonics, Cerex Biopharma, and Pfizer, and is on the speaker's bureaus of Eli Lilly and Bristol-Myers Squibb. Dr. Carlat has found that there is no evidence of commercial bias in this educational activity.